Naoki Sasahira

11PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersHydrometallurgyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 19, 2026
Association between ABCB1 genetic polymorphisms with treatment outcomes in patients with metastatic pancreatic cancer.

|Sep 12, 2026
Comparison of Two Partially Covered Metal Stents for Endoscopic Ultrasound-guided Hepaticogastrostomy: A Multi-Center Retrospective Study.

|Aug 28, 2026
Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba, Masato Ozaka, Junki Mizusawa

|Apr 10, 2025
Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency.

Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu

Pageof 2

Frequent Collaborators

5 joint publications

Masato Ozaka

4 joint publications

Takeshi Okamoto

3 joint publications

Tsuyoshi Takeda

3 joint publications

Takashi Sasaki